PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea

被引：11
|
作者：
Sun, Jong-Mu
Zhou, Wei
Choi, Yoon-La
Choi, So-Jung
Kim, Se Eun
Wang, Zhen
Dolled-Filhart, Marisa
Emancipator, Kenneth
Weiner, Russell
Park, Minjin
Kim, Hong Kwan
Choi, Yong Soo
Shim, Young Mog
Kim, Jhingook
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[2] Merck Res Labs, Beijing, Peoples R China
[3] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, SBRI, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[6] Merck, Beijing, Peoples R China
[7] Merck & Co Inc, Whitehouse Stn, NJ USA
[8] Merck Res Labs, Rahway, NJ USA
[9] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8066
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [2] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    [J]. ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [4] Association of PD-L1 expression with hotspot mutations in non-small cell lung cancer (NSCLC).
    Wan, Renping
    Zhang, Xiaoni
    Qu, Hongyue
    Li, Hui
    Li, Yingmei
    Xu, Mingyan
    Xiao, Yun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [6] Comparative study of two PD-L1 expression assays in patients with non-small cell lung cancer (NSCLC).
    Feng, Zheng
    Schlichting, Michael
    Helwig, Christoph
    Chand, Vikram K.
    Gelb, Arnold
    Jin, Hulin
    Grote, Hans Juergen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] PD-L1 expression by RNA-sequencing and survival from pembrolizumab in non-small cell lung cancer (NSCLC)
    Nesline, Mary K.
    Pabla, Sarabjot
    Lee, Yong Hee
    DePietro, Paul
    Early, Amy
    Klein, Roger
    Zhang, Shengle
    Conroy, Jeffrey
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [8] PD-L1 Tumor Expression and Its Effect on Overall Survival among Patients with Resected Non-Small Cell Lung Cancer (NSCLC)
    Sul, Jane
    Teo, Min Yuen
    Rafee, Shereen
    Mc Fadden, Julie
    Gately, Kathy
    Barr, Martin
    Gray, Steven
    Cuffe, Sinead
    Finn, Stephen
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S827 - S827
  • [9] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
  • [10] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
12345